surmount-1 tirzepatide trial obesity without diabetes cuts risk by 94% in Efficacy and safety of once-weekly

1) A physician-guided intake that screens for the dont do this scenarios We start by identifying patients who may be poor candidates or need extra caution, such as: Pregnancy, trying to conceive, or breastfeeding Personal/family history of medullary thyroid cancer or MEN2 Prior pancreatitis (individualized risk discussion) Significant GI disease with poor tolerance potential Active eating disorder or uncontrolled restrictive patterns Frailty, very low baseline intake, or high risk for muscle loss We also review medication interactions and hypoglycemia risk in patients using insulin or certain diabetes medications

Acute Gallbladder Disease: Patients should be monitored for signs and symptoms of acute gallbladder disease

All medications are HSA and FSA eligible, and PlexusDx partners with licensed 503A compounding pharmacies to ensure pharmaceutical quality and safety standards

PST Treatments Offered Weekly GLP-1 injections: compounded semaglutide Daily GLP1 Injections: compounded liraglutide Daily oral GLP-1s: compounded tirzepatide (dissolving tablets) and semaglutide (drops or dissolving tablets) Daily (13 times) oral weight-loss medications: phentermine (SR capsules or tablets) and topiramate Additional services: testosterone therapy, womens HRT Bottom Line Henry Meds keeps things affordable and easy for those who just want a prescription

What Results May Look Like by Dose Clinical trial results show that higher tirzepatide doses are associated with greater average weight loss, but individual results vary

Tirzepatide can work differently when taken with other medications